Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
5.55M
-
Shares change
-
-183K
-
Total reported value, excl. options
-
$244M
-
Value change
-
-$8.64M
-
Put/Call ratio
-
0.26
-
Number of buys
-
53
-
Number of sells
-
-40
-
Price
-
$43.99
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q1 2024
107 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q1 2024.
IRADIMED CORP - Common Stock (IRMD) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.55M shares
of 12.7M outstanding shares and own 43.6% of the company stock.
Largest 10 shareholders include Nine Ten Capital Management LLC (809K shares), BlackRock Inc. (659K shares), RENAISSANCE TECHNOLOGIES LLC (573K shares), VANGUARD GROUP INC (426K shares), Soleus Capital Management, L.P. (362K shares), RK Capital Management, LLC (299K shares), Bares Capital Management, Inc. (279K shares), Ranger Investment Management, L.P. (232K shares), DIMENSIONAL FUND ADVISORS LP (217K shares), and GEODE CAPITAL MANAGEMENT, LLC (168K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.